Accel Research Sites recruiting for multiple RSV clinical trials - Accel Research Sites

Create a Profile

I accept digital forms of communication(Required)
Hidden
Hidden
This field is for validation purposes and should be left unchanged.
Create a Profile
I accept digital forms of communication(Required)
Hidden
Hidden
This field is for validation purposes and should be left unchanged.

Get In Touch Mobile

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location
Back
Date Published: 11/02/2022

Accel Research Sites recruiting for multiple RSV clinical trials

While the world celebrates the development of COVID-19 vaccines, another vaccine breakthrough is waiting in the wings—and six Accel Research Sites in Florida, Georgia and Alabama will be part of it.

Accel Research Sites is currently enrolling for multiple trials for vaccine candidates against Respiratory Syncytial Virus, or RSV.

RSV is a respiratory virus that can be deadly for infants and adults 60 or older. Researchers have been working on these important vaccines for years to help prevent illness in these vulnerable populations. Now, several vaccines are in the final trial stages, and approvals could be close at hand.

“RSV can be a big threat to the older population,” said Lora Parahovnik, CEO of Accel Research Sites. “It’s exciting that we’re at a point when multiple vaccines are being seriously considered for approval. We hope participants will be motivated to be part of this progress and potentially take advantage of the latest medical advancements for their own health.”

Accel and research sites across the country are seeking participants 60 and older to help move medicine forward. The company is recruiting for sites in DeLand, Lakeland, Maitland and St. Petersburg in Florida, as well as in Birmingham, Alabama and Lake Oconee, Georgia.

Principal investigators are Dr. Bruce Rankin, Dr. James Andersen, Dr. Eva-Maria Heurich, Dr. Gigi Lefebvre, Dr. Hayes Williams and Dr. Nicolas Chronos. Trials are enrolling mid-February through the end of March.

Those interested in participating should visit https://accelresearchsites.com/get-started/ and a member of the Accel team will reach out to determine eligibility.

Back

Ready to be part of healthcare history? Find the right clinical trial for you.

Get In Touch

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.
Accessibility Adjustment

Color Adjustment

Orientation Adjustment

Font Size

 

Line height